EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fluorinated Benzofuran and Dihydrobenzofuran as Anti-Inflammatory and Potential Anticancer Agents

Abeer J Ayoub, Ghewa A El-Achkar, Sandra E Ghayad, Layal Hariss, Razan H Haidar, Leen M Antar, Zahraa I Mallah, Bassam Badran, René Grée, Ali Hachem, Eva Hamade, Aida Habib iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241210399 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Abeer J Ayoub und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Genetics, Faculty of Medicine, American University of Beirut, Beirut 1107 2020, Lebanon. Hauptthemen laut MEDLINE: Antineoplastic Agents, Benzofurans. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Lebanese University, Research Grant Program at the Lebanese University, College of Medicine, QU Health, Qatar University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Benzofuran and 2,3-dihydrobenzofuran scaffolds are heterocycles of high value in medicinal chemistry and drug synthesis. Targeting inflammation in cancer associated with chronic inflammation is a promising therapy. In the present study, we investigated the anti-inflammatory effects of fluorinated benzofuran and dihydrobenzofuran derivatives in macrophages and in the air pouch model of inflammation, as well as their anticancer effects in the human colorectal adenocarcinoma cell line HCT116. Six of the nine compounds suppressed lipopolysaccharide-stimulated inflammation by inhibiting the expression of cyclooxygenase-2 and nitric oxide synthase 2 and decreased the secretion of the tested inflammatory mediators. Their IC50 values ranged from 1.2 to 9.04 µM for interleukin-6; from 1.5 to 19.3 µM for Chemokine (C-C) Ligand 2; from 2.4 to 5.2 µM for nitric oxide; and from 1.1 to 20.5 µM for prostaglandin E2. Three novel synthesized benzofuran compounds significantly inhibited cyclooxygenase activity. Most of these compounds showed anti-inflammatory effects in the zymosan-induced air pouch model. Because inflammation may lead to tumorigenesis, we tested the effects of these compounds on the proliferation and apoptosis of HCT116. Two compounds with difluorine, bromine, and ester or carboxylic acid groups inhibited the proliferation by approximately 70%. Inhibition of the expression of the antiapoptotic protein Bcl-2 and concentration-dependent cleavage of PARP-1, as well as DNA fragmentation by approximately 80%, were described. Analysis of the structure–activity relationship suggested that the biological effects of benzofuran derivatives are enhanced in the presence of fluorine, bromine, hydroxyl, and/or carboxyl groups. In conclusion, the designed fluorinated benzofuran and dihydrobenzofuran derivatives are efficient anti-inflammatory agents, with a promising anticancer effect and a combinatory treatment in inflammation and tumorigenesis in cancer microenvironments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsBenzofuransHumansBromineAnti-Inflammatory AgentsCyclooxygenase 2Nitric Oxide Synthase Type IIInflammationCarcinogenesisNitric OxideLipopolysaccharidesTumor Microenvironment

Stichwörter der Autor:innen

HCT116 cellsbenzofurancyclooxygenase-2inflammationmacrophageprostaglandin E2

Substanzen

BromineAntineoplastic AgentsAnti-Inflammatory AgentsCyclooxygenase 2Nitric Oxide Synthase Type IIBenzofuransNitric OxideLipopolysaccharides

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Genetics, Faculty of Medicine, American University of Beirut, Beirut 1107 2020, Lebanon.
  • Laboratory of Cancer Biology and Molecular Immunology, Faculty of Sciences I, Lebanese University, Hadath 1104, Lebanon.
  • Department of Biological Sciences, School of Arts and Sciences, Lebanese International University, Bekaa Campus, Bekaa 146404, Lebanon.
  • Faculty of Medicine, Saint George University of Beirut, Achrafieh, Beirut 1100-2807, Lebanon.
  • Department of Biology, Faculty of Sciences II, EDST, Lebanese University, Fanar 90656, Lebanon.
  • Center for CardioVascular and Nutrition Research (C2VN), INSERM 1263, INRAE 1260, Aix-Marseille University, 13385 Marseille, France.

ORCID-Profile: Aida Habib

Förderung

  • Lebanese University
  • Research Grant Program at the Lebanese University
  • College of Medicine, QU Health, Qatar University

Zitieren

APA

Ayoub, A. J., El-Achkar, G. A., Ghayad, S. E., Hariss, L., Haidar, R. H., Antar, L. M., Mallah, Z. I., Badran, B., Grée, R., Hachem, A., Hamade, E., & Habib, A. (2023). Fluorinated Benzofuran and Dihydrobenzofuran as Anti-Inflammatory and Potential Anticancer Agents. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241210399

Vancouver

Ayoub AJ, El-Achkar GA, Ghayad SE, Hariss L, Haidar RH, Antar LM, et al. Fluorinated Benzofuran and Dihydrobenzofuran as Anti-Inflammatory and Potential Anticancer Agents. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241210399

BibTeX
@article{Ayoub2023,
  author = {Ayoub, Abeer J and El-Achkar, Ghewa A and Ghayad, Sandra E and Hariss, Layal and Haidar, Razan H and Antar, Leen M and Mallah, Zahraa I and Badran, Bassam and Grée, René and Hachem, Ali and Hamade, Eva and Habib, Aida},
  title = {Fluorinated Benzofuran and Dihydrobenzofuran as Anti-Inflammatory and Potential Anticancer Agents},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241210399}
}
Kostenlos starten →